Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC
NCT07177105
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
118
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
PROCEDURE:
Cytoreductive surgery
DRUG:
Immunochemotherapy
Sponsor
Jianxing He